These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18522490)

  • 1. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications.
    Basu S
    Antioxid Redox Signal; 2008 Aug; 10(8):1405-34. PubMed ID: 18522490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid oxidation and isoprostanes: oxidative strain and oxidative stress.
    Basu S
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):219-25. PubMed ID: 20363116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprostanes: novel bioactive products of lipid peroxidation.
    Basu S
    Free Radic Res; 2004 Feb; 38(2):105-22. PubMed ID: 15104204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive eicosanoids: role of prostaglandin F(2α) and F₂-isoprostanes in inflammation and oxidative stress related pathology.
    Basu S
    Mol Cells; 2010 Nov; 30(5):383-91. PubMed ID: 21113821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprostanes: markers and mediators of oxidative stress.
    Montuschi P; Barnes PJ; Roberts LJ
    FASEB J; 2004 Dec; 18(15):1791-800. PubMed ID: 15576482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isoprostanes: new markers of oxidative stress in human diseases].
    Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
    Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F(2)-isoprostanes as novel biomarkers for type 2 diabetes: a review.
    Kaviarasan S; Muniandy S; Qvist R; Ismail IS
    J Clin Biochem Nutr; 2009 Jul; 45(1):1-8. PubMed ID: 19590700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F2-isoprostanes as markers of oxidative stress in vivo: an overview.
    Milne GL; Musiek ES; Morrow JD
    Biomarkers; 2005 Nov; 10 Suppl 1():S10-23. PubMed ID: 16298907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues.
    Halliwell B; Lee CY
    Antioxid Redox Signal; 2010 Jul; 13(2):145-56. PubMed ID: 20001743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects].
    Cracowski JL; Stanke-Labesque F; Bessard G
    Rev Med Interne; 2000 Mar; 21(3):304-7. PubMed ID: 10763198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key issues in F2-isoprostane analysis.
    Nourooz-Zadeh J
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):1060-5. PubMed ID: 18793189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of oxidized lipid products of marine fish under acute oxidative stress.
    Chung ML; Lee KY; Lee CY
    Food Chem Toxicol; 2013 Mar; 53():205-13. PubMed ID: 23220612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism.
    Klein T; Neuhaus K; Reutter F; Nüsing RM
    Br J Pharmacol; 2001 Jul; 133(5):643-50. PubMed ID: 11429387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors regulating isoprostane formation in vivo.
    Basu S; Helmersson J
    Antioxid Redox Signal; 2005; 7(1-2):221-35. PubMed ID: 15650410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of F(2)-isoprostanes unveils profound oxidative stress in aged rats.
    Roberts LJ; Reckelhoff JF
    Biochem Biophys Res Commun; 2001 Sep; 287(1):254-6. PubMed ID: 11549283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
    Piłacik B; Nofer TW; Wasowicz W
    Int J Occup Med Environ Health; 2002; 15(1):19-27. PubMed ID: 12038860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F2-isoprostanes as markers of oxidant stress: an overview.
    Musiek ES; Morrow JD
    Curr Protoc Toxicol; 2005 Jun; Chapter 17():Unit 17.5. PubMed ID: 23045114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of F2-isoprostanes as a biomarker of oxidative stress.
    Milne GL; Sanchez SC; Musiek ES; Morrow JD
    Nat Protoc; 2007; 2(1):221-6. PubMed ID: 17401357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F2-isoprostanes in Alzheimer and other neurodegenerative diseases.
    Montine TJ; Montine KS; McMahan W; Markesbery WR; Quinn JF; Morrow JD
    Antioxid Redox Signal; 2005; 7(1-2):269-75. PubMed ID: 15650414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
    Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.